Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 22339928)

1.

Long-term use of antimalarial drugs in rheumatic diseases.

Jover JA, Leon L, Pato E, Loza E, Rosales Z, Matias MA, Mendez-Fernandez R, Díaz-Valle D, Benitez-Del-Castillo JM, Abasolo L.

Clin Exp Rheumatol. 2012 May-Jun;30(3):380-7. Epub 2012 Jun 26.

PMID:
22339928
2.

Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.

Morrison FJ, Zhang H, Skentzos S, Shubina M, Bentley-Lewis R, Turchin A.

Cardiorenal Med. 2014 Dec;4(3-4):225-33. doi: 10.1159/000368914. Epub 2014 Nov 19.

3.
4.

Chloroquine cardiomyopathy: beyond ocular adverse effects.

Lopez-Ruiz N, Uribe CE.

BMJ Case Rep. 2014 Sep 15;2014. pii: bcr2014205751. doi: 10.1136/bcr-2014-205751.

PMID:
25225192
5.

Antimalarials in dermatology: mechanism of action, indications, and side effects.

Rodriguez-Caruncho C, Bielsa Marsol I.

Actas Dermosifiliogr. 2014 Apr;105(3):243-52. doi: 10.1016/j.adengl.2012.10.021. Epub 2014 Mar 18. Review.

PMID:
24656224
6.

Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist.

Pincus T, Braun J, Kavanaugh A, Smolen JS.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S1-3. Epub 2013 Oct 3. No abstract available.

PMID:
24129127
7.

[Screening investigations during intensified immunosuppression in children and adolescents. Part 1].

Speth F, Wellinghausen N, Haas JP.

Z Rheumatol. 2013 Oct;72(8):814-21. doi: 10.1007/s00393-013-1200-3. Review. German.

PMID:
23929241
8.

Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases.

de Andrade BA, Fonseca FP, Pires FR, Mesquita AT, Falci SG, Dos Santos Silva AR, Vargas PA, Jorge J, de Almeida OP.

J Cutan Pathol. 2013 Sep;40(9):833-8. doi: 10.1111/cup.12182. Epub 2013 Jun 19.

PMID:
23782298
9.

Retinal toxicity due to antimalarials: frequency and risk factors.

Palma Sánchez D, Rubio Velazquez E, Soro Marín S, Reyes García R.

Reumatol Clin. 2013 Sep-Oct;9(5):259-62. doi: 10.1016/j.reuma.2012.10.011. Epub 2013 May 23. English, Spanish.

10.

Chloroquine cardiomyopathy - a review of the literature.

Tönnesmann E, Kandolf R, Lewalter T.

Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42. doi: 10.3109/08923973.2013.780078. Epub 2013 May 1. Review.

PMID:
23635029
11.

[Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns].

Tarfaoui N, Autret-Leca E, Mazjoub S, Cissoko H, Jonville-Béra AP.

Therapie. 2013 Jan-Feb;68(1):43-7. doi: 10.2515/therapie/2013003. Epub 2013 Mar 14. Review. French.

PMID:
23484660
12.

Antimalarial myopathy in amyopathic dermatomyositis.

Foulke G, Baccon J, Marks JG, Clarke JT.

Arch Dermatol. 2012 Sep;148(9):1100-1. doi: 10.1001/archdermatol.2012.1711. No abstract available.

PMID:
22986884
13.

Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs.

Hromadkova L, Soukup T, Vlcek J.

Drugs Today (Barc). 2012 Aug;48(8):545-53. doi: 10.1358/dot.2012.48.8.1841300. Review.

PMID:
22916342
14.

Malignancy as a comorbidity in rheumatic diseases.

Turesson C, Matteson EL.

Rheumatology (Oxford). 2013 Jan;52(1):5-14. doi: 10.1093/rheumatology/kes189. Epub 2012 Jul 23. Review.

15.

[Rheumatic diseases during pregnancy].

Fischer-Betz R.

Internist (Berl). 2012 Sep;53(9):1047-53. doi: 10.1007/s00108-012-3029-2. German.

PMID:
22695896
16.

Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance Network.

Jourde-Chiche N, Mancini J, Dagher N, Taugourdeau S, Thomas G, Brunet C, Bornet C, Pastor MJ, Chiche L.

Ann Rheum Dis. 2012 Sep;71(9):1586. doi: 10.1136/annrheumdis-2011-201265. Epub 2012 Apr 13. No abstract available.

PMID:
22504560
17.

Chloroquine-induced hyperpigmentation of the hard palate.

Brasil Cda M, Ribeiro CM, Fonseca DD, Gueiros LA, Leao JC.

Gen Dent. 2012 Mar-Apr;60(2):e74-8.

PMID:
22414521
18.

Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Missner S, Kellner U.

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):319-25. doi: 10.1007/s00417-011-1753-2. Epub 2012 Jan 4.

PMID:
22215255
19.

5-Phenyl-2,4-pentadienamides as Potential Antimalarial Agents.

Werbel LM, Headen N, Elslager EF.

J Med Chem. 1967 May 1;10(3):366-70. doi: 10.1021/jm00315a018. No abstract available.

PMID:
22185134
20.

[Duration of treatment with etanercept and motives for discontinuation in a cohort of patients with rheumatic disease].

Senabre-Gallego JM, Rosas-Gómez de Salazar J, Santos-Soler G, Santos-Ramírez C, Sánchez-Barrioluengo M, Salas-Heredia E, Barber-Vallés X, Cano-Pérez C, Llahí-Vidal N, Riestra-Juán R.

Reumatol Clin. 2011 Nov-Dec;7(6):385-8. doi: 10.1016/j.reuma.2011.06.005. Epub 2011 Oct 24. Spanish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk